You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 9月15日港股收盤

根據uSMART輿情監測數據,15日港股交易時段,市場關注指數最高的3只股票是碧桂園、藥明生物、復星國際。

9月15日—港股關注排行TOP3

輿情變化榜單

碧桂園

個股K線圖

關注度第一爲碧桂園,該股今日收盤上漲8.71%,報於2.62港元。近5個交易日累計上漲11.02%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

恆指漲0.44% 內房股、物業股漲幅居前 碧桂園漲超9%

內房股、物管股集體爆發 碧桂園大漲超10% CRO板塊反彈 電力股集體走弱

藥明生物

個股K線圖

關注度第二爲藥明生物,該股今日收盤上漲6.59%,報於54.15港元。近5個交易日累計下跌14.45%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

恆指跌0.07% 恆生科技指數跌0.34% 醫藥股反彈 藥明生物漲超5%

港股CRO板塊反彈 藥明生物漲5% 拜登生物技術行政命令細節落地

復星國際

個股K線圖

關注度第三爲復星國際,該股今日收盤上漲9.65%,報於5.00港元。近5個交易日累計下跌2.15%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:

復星國際反彈逾3% 近日拜會北京市國資委藉此消除市場憂慮

復星國際升超5% 月內數次回購累計耗資超0.7億港元

此外,監測期內有1只股票的輿情出現大扭轉,意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。

9月15日—港股輿情轉折預警

輿情變化榜單

復星國際

個股K線圖

復星國際輿情扭轉指數達100,目前輿情方向爲利好,表明公司出現了被投資者視作較大利好的消息。

其中較被市場關注的消息有:

復星國際反彈逾3% 近日拜會北京市國資委藉此消除市場憂慮

復星國際升超5% 月內數次回購累計耗資超0.7億港元

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account